FDA Submits Peptide Policy to White House — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- FDA submitted a peptide "interim access policy" to the White House for review this week, according to a government filing.
- RFK Jr. is driving the peptide access push, per the newsletter's headline framing of the FDA submission.
Why it matters: The FDA submission moves the peptide access proposal one step closer to potential implementation, but the White House review stage means the policy's final form and timing remain undetermined by anything stated in the source.
Ask SkimNews
